FIELD: biotechnology.
SUBSTANCE: there are presented: recombinant vesicular stomatitis virus expressing chimeric protein IL12-GMCSF and its use as a preparation with anticancer activity.
EFFECT: declared virus has pronounced oncolytic ability and can be used for treating oncological diseases.
6 cl, 13 dwg, 2 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING RECOMBINANT VESICULAR STOMATITIS VIRUS | 2022 |
|
RU2807751C1 |
| MULTIPURPOSE CANCER-SPECIFIC PROMOTERS AND USING THEM IN ANTI-CANCER THERAPY | 2013 |
|
RU2539764C2 |
| RECOMBINED PLASMID DNA CODING CHIMERIC ANTIBODY AGAINST HUMAN TUMOUR NECROSIS FACTOR-ALPHA, EUKARYOTIC CELL LINE PRODUCING CHIMERIC ANTIBODY, AND METHOD OF CHIMERIC ANTIBODY OBTAINMENT | 2013 |
|
RU2555533C9 |
| PEPTIDE MPI WITHOUT SIGNAL SEQUENCE, DNA ENCODING THEREOF, VECTOR, METHOD FOR ASSAY CAPACITY FOR SECRETION OF TESTING PEPTIDE, METHOD FOR ISOLATING CDNA | 1998 |
|
RU2230751C2 |
| METHOD OF PRODUCING TARGET VIRUS OR TARGET PROTEINS DIFFERENT FROM ADENOVIRUS, EXPRESSION CELL AND HOST CELL AND PRODUCTION METHODS THEREOF, USE OF EXPRESSION CELL | 2006 |
|
RU2449015C2 |
| MONOMOLECULAR CHIMERIC T-CELL RECEPTOR TO CANCER ANTIGEN CA125 | 2018 |
|
RU2747095C2 |
| HISTONES AND BIODEGRADABLE LIPIDES AS MEANS FOR NUCLEIC ACIDS DELIVERY TO EUKARYOTIC CELLS | 2015 |
|
RU2637371C2 |
| MODIFIED INTERLEUKIN-7 PROTEIN AND METHODS FOR USE THEREOF | 2016 |
|
RU2708160C2 |
| ADENOVIRAL VECTORS AND RELATED METHODS AND APPLICATIONS | 2009 |
|
RU2520823C2 |
| RECOMBINANT PLASMID DNA PBIPR-ABIGA1FI6-HT FOR OBTAINING RECOMBINANT IMMUNOGLOBULIN A IGOTH IGA1 | 2016 |
|
RU2656142C1 |
